For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, INmune Bio Inc (NASDAQ: INMB) closed at $2.31 up 3.59% from its previous closing price of $2.23. In other words, the price has increased by $3.59 from its previous closing price. On the day, 1.4 million shares were traded. INMB stock price reached its highest trading level at $2.3492 during the session, while it also had its lowest trading level at $2.18.
Ratios:
For a deeper understanding of INmune Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.64 and its Current Ratio is at 2.64. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 28, 2025, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $23.Rodman & Renshaw initiated its Buy rating on January 28, 2025, with a $23 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 30 ’24 when Moss David J bought 10,000 shares for $5.29 per share. The transaction valued at 52,868 led to the insider holds 1,285,869 shares of the business.
Tesi Raymond Joseph bought 15,380 shares of INMB for $98,048 on Sep 12 ’24. The President and CEO now owns 1,554,106 shares after completing the transaction at $6.38 per share. On Sep 12 ’24, another insider, Moss David J, who serves as the Chief Financial Officer of the company, bought 7,690 shares for $6.38 each. As a result, the insider paid 49,024 and bolstered with 1,275,869 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INMB now has a Market Capitalization of 62924628 and an Enterprise Value of 34625972. For the stock, the TTM Price-to-Sale (P/S) ratio is 1228.20 while its Price-to-Book (P/B) ratio in mrq is 1.79. Its current Enterprise Value per Revenue stands at 692.519.
Stock Price History:
The Beta on a monthly basis for INMB is 0.96, which has changed by -0.7576076 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, INMB has reached a high of $11.64, while it has fallen to a 52-week low of $1.89. The 50-Day Moving Average of the stock is -64.16%, while the 200-Day Moving Average is calculated to be -64.85%.
Shares Statistics:
For the past three months, INMB has traded an average of 2.47M shares per day and 12262240 over the past ten days. A total of 22.93M shares are outstanding, with a floating share count of 18.90M. Insiders hold about 28.90% of the company’s shares, while institutions hold 27.86% stake in the company. Shares short for INMB as of 1749772800 were 7256955 with a Short Ratio of 4.22, compared to 1747267200 on 5870122. Therefore, it implies a Short% of Shares Outstanding of 7256955 and a Short% of Float of 38.48.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
